科研速览 · Science Skim继续刷下去 · Keep skimming →
◆ International Journal of Advanced Research2026-07-31· Medicine

TO EVALUATE THE EFFICACY AND SAFETY OF ZINC AS AN ADD ON THERAPY TO PREDNISOLONE FOR PRODUCING EARLY REMISSION OF PEDIATRIC NEPHROTIC SYNDROME : A RANDOMIZED CONTROLLED TRIAL

Alok Kaushik, Garima Bhutani, Manoj Rawal, Renu Garg, Seema Rani, Rahul Saini

原始摘要(英文原文)· Original abstract
Introduction: Nephrotic syndrome is a common pediatric kidney disorder characterized by heavy proteinuria, hypoalbuminemia, edema, and hyperlipidemia. Zinc deficiency is common due to urinary losses and may delay recovery. This study evaluated the efficacy and safety of zinc as an adjunct to prednisolone in achieving early remission. Materials and Methods: A prospective, open-label, randomized comparative study was conducted in 62 children (1-15 years) with first-episode nephrotic syndrome. Patients received either prednisolone plus zinc (n=31) or prednisolone alone (n=31). Urinary protein, urinary protein-creatinine ratio, urine output, fluid intake, body weight, abdominal girth, and blood pressure were monitored daily. Serum electrolytes (Na+, K+), total protein, albumin, globulin, A:G ratio, lipid profile, serum creatinine, and serum urea were measured at baseline and at remission.
读原文 · Read the paper ↗

AI 追问PRO

登录后使用 AI 追问

讨论区

登录后参与讨论

相关论文 · Related

TO EVALUATE THE EFFICACY AND SAFETY OF ZINC AS AN ADD ON THERAPY TO PREDNISOLONE FOR PRODUCING EARLY REMISSION OF PEDIATRIC NEPHROTIC SYNDROME : A RANDOMIZED CONTROLLED TRIAL — 科研速览 Science Skim